Pharma Pulse 9/10/24: How Satellite Sites Are Outpacing Decentralized Models, Large Numbers of People Clinically Eligible for GLP-1 Drugs & more

Pharmaceutical Executive September 10, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Revolutionizing Clinical Trials: How Satellite Sites Are Outpacing Decentralized Models for Faster, More Inclusive Research

Improving accessibility drives faster and more efficient patient enrollment and a more diverse trial population.

KFF: Large Numbers of People Clinically Eligible for GLP-1 Drugs

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on currently approved FDA indications, including 36.2 million people with obesity.

A.I. Isn’t Magic, but Can It Be ‘Agentic’?

So-called agentic artificial intelligence doesn’t require a human to tell it what to do. At least, that’s the idea.

Battelle Awarded U.S. Department of Defense Contract to Develop an Improved Nerve Agent Countermeasure

Battelle...

Today's Sponsors

Today's Sponsor